1. Home
  2. ALLO vs ASUR Comparison

ALLO vs ASUR Comparison

Compare ALLO & ASUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLO
  • ASUR
  • Stock Information
  • Founded
  • ALLO 2017
  • ASUR 1985
  • Country
  • ALLO United States
  • ASUR United States
  • Employees
  • ALLO N/A
  • ASUR N/A
  • Industry
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • ASUR EDP Services
  • Sector
  • ALLO Health Care
  • ASUR Technology
  • Exchange
  • ALLO Nasdaq
  • ASUR Nasdaq
  • Market Cap
  • ALLO 277.8M
  • ASUR 258.8M
  • IPO Year
  • ALLO 2018
  • ASUR 1992
  • Fundamental
  • Price
  • ALLO $1.21
  • ASUR $11.35
  • Analyst Decision
  • ALLO Strong Buy
  • ASUR Strong Buy
  • Analyst Count
  • ALLO 9
  • ASUR 6
  • Target Price
  • ALLO $8.44
  • ASUR $14.58
  • AVG Volume (30 Days)
  • ALLO 2.5M
  • ASUR 76.6K
  • Earning Date
  • ALLO 08-06-2025
  • ASUR 07-31-2025
  • Dividend Yield
  • ALLO N/A
  • ASUR N/A
  • EPS Growth
  • ALLO N/A
  • ASUR N/A
  • EPS
  • ALLO N/A
  • ASUR N/A
  • Revenue
  • ALLO N/A
  • ASUR $122,994,000.00
  • Revenue This Year
  • ALLO N/A
  • ASUR $15.40
  • Revenue Next Year
  • ALLO $199.63
  • ASUR $9.27
  • P/E Ratio
  • ALLO N/A
  • ASUR N/A
  • Revenue Growth
  • ALLO N/A
  • ASUR 4.53
  • 52 Week Low
  • ALLO $0.86
  • ASUR $7.51
  • 52 Week High
  • ALLO $3.78
  • ASUR $12.74
  • Technical
  • Relative Strength Index (RSI)
  • ALLO 43.73
  • ASUR 73.21
  • Support Level
  • ALLO $1.11
  • ASUR $9.54
  • Resistance Level
  • ALLO $1.29
  • ASUR $10.13
  • Average True Range (ATR)
  • ALLO 0.09
  • ASUR 0.44
  • MACD
  • ALLO -0.01
  • ASUR 0.17
  • Stochastic Oscillator
  • ALLO 25.81
  • ASUR 95.22

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About ASUR Asure Software Inc

Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its HCM products majorly in the United States.

Share on Social Networks: